Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1719200

registered interest
date	20/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Licensing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what flexibility (a) NICE and (b) NHS England have to approve for use drugs that (i) are used in combination with other drugs, (ii) are used for various (A) conditions and (B) lines of treatment and (iii) provide significant benefits for some but not all patients; and what tools those organisations use to ensure the effectiveness of such appraisals.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	27051
answer	answer is ministerial correction date of answer 23/05/2024 answer text <p>The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines, and significant licence extensions for existing medicines, should be routinely funded by the NHS. The NICE is able to recommend most new medicines for use by the NHS, including as a result of commercial agreements negotiated between NHS England and the company, in line with the commercial framework for new medicines.</p><p>The NICE develops its guidance in line with its published health technology evaluations manual, which sets out the circumstances in which its Appraisal Committees are able to apply flexibility in the evaluation of specific treatments. The NICE is, for example, able to apply a modifier in the evaluation of medicines for severe diseases that means that its committees are able to recommend medicines at a higher cost-effectiveness threshold than for less severe diseases. The NICE appraises combination therapies using the same methods that it uses for appraising single drug therapies.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 23/05/2024 16:08:56 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4370 label Biography information for Jess Phillips

1716421

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions she (a) has had and (b) plans to have with (i) charities and (ii) other organisations working to secure UK access to new drugs for (A) incurable, (B) relapsing and (C) remitting cancers such as myeloma.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	25238
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Department ministers and officials regularly meet with a range of organisations, with an interest in securing patient access to new cancer medicines. The National Institute for Health and Care Excellence (NICE) is the body that develops authoritative, evidence-based guidance for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits, including medicines for myeloma. The NICE aims to publish guidance on all new medicines close to the point of licensing wherever possible, and has recommended many cancer medicines for NHS use that are now available to NHS patients, including through the Cancer Drugs Fund.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:43:01 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4370 label Biography information for Jess Phillips

1716422

registered interest
date	08/05/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether she (a) has had discussions and (b) plans to have discussions with the National Institute for Health and Care Excellence on (i) its use of the new severity modifier and (ii) how it (A) measures and (B) reports the impact of the modifier on approval of treatments for (1) cancers, (2) relapsing and remitting conditions and (3) conditions that are more prevalent in older people.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	25239
answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The Department regularly meets with colleagues in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including in relation to the NICE’s methods for the evaluation of medicines. In 2022, the NICE introduced a number of changes to make its methods and processes fairer, faster, and more consistent. This includes the introduction of a broader severity modifier, in place of the end-of-life modifier. Since the changes were introduced, 79% of the NICE’s appraisals of cancer medicines carried out under the updated methods have recommended the use of the treatment for some or all of the eligible patient population, either for routine use or use through the Cancer Drugs Fund. The approval rate for all cancer appraisals carried out since 2009, when the end-of-life modifier was introduced, is 78%.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:48:27 answering member 4044 label Biography information for Andrew Stephenson
tabling member	4370 label Biography information for Jess Phillips

1697125

registered interest
date	19/03/2024
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sexual Assault Referral Centres
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England has completed its review of service provision of June 2022 to determine whether forensic and medical interventions for non-fatal strangulation which occur in domestic abuse should form part of the core offer for sexual assault referral centres or should be cared for elsewhere.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	19379
answer	answer is ministerial correction date of answer 28/03/2024 answer text <p>The National Sexual Assault Referral Centre’s (SARC) Service Specification, as reviewed and updated in June 2023, now reflects the offence of non-fatal strangulation (NFS). The specification states: Appropriate medical and forensic interventional support is provided to all service users presenting with sexual assault and/or sexual abuse where the presenting need also indicates non-fatal strangulation. It is widely acknowledged that many victims of sexual assault will have also experienced domestic abuse.</p><p>For cases of non-fatal strangulation not associated with sexual assault, victims’ immediate healthcare needs can be treated in other acute healthcare settings such as emergency departments. The Institute for Addressing Strangulation recently published guidelines for clinical management of non-fatal strangulation in acute and emergency care services.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 28/03/2024 14:33:37 answering member 4492 label Biography information for Maria Caulfield
tabling member	4370 label Biography information for Jess Phillips

1671966

registered interest
date	21/11/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Sexual Assault Referral Centres: Domestic Abuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the Answer of 8 June 2022 to Question 11698 on Domestic Abuse: Sexual Assault Referral Centres, whether NHS England has completed its review of service provision to determine whether forensic and medical interventions for non-fatal strangulation should form part of the core offer for sexual assault referral centres.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	2904
answer	answer is ministerial correction date of answer 27/11/2023 answer text <p>The National Sexual Assault Referral Centre (SARC) Service Specification as reviewed and updated in June 2023 now reflects the offence of non-fatal strangulation. The specification states ‘Appropriate medical and forensic interventional support is provided to all service users presenting with sexual assault and/or sexual abuse where the presenting need also indicates non-fatal strangulation.’ It also references the Institute for Addressing Strangulation guidelines. From April 2024, all SARCs will collect data on incidences of non-fatal strangulation where it is part of a sexual assault/rape and thus has necessitated attendance at a SARC.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 27/11/2023 17:41:57 answering member 4492 label Biography information for Maria Caulfield
tabling member	4370 label Biography information for Jess Phillips

1612510

registered interest
date	19/04/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Healthcare Travel Costs Scheme: Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to provide financial support for the cost of travelling to hospital by cancer patients who do not qualify for the Healthcare Travel Costs Scheme.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	181800
answer	answer is ministerial correction date of answer 24/04/2023 answer text <p>Patients who do not qualify for the HTCS and are on low incomes may be able to claim the costs from the Department for Work and Pensions through the Universal Credit or Personal Independence Payment schemes.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 24/04/2023 18:24:35 answering member 4527 label Biography information for Helen Whately previous answer version 70715 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	4370 label Biography information for Jess Phillips

1546166

registered interest
date	28/11/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Organs: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people are on the organ donation waiting list in the West Midlands as of 28 November 2022; what the average waiting time was for an organ donation in the West Midlands in the latest period for which data is available; how many organ transplants took place in the West Midlands in the latest period for which data is available; and how many people were taken off the waiting list for an organ donation due to a clinical decision in the West Midlands in (a) 2019, (b) 2020 and (c) 2021.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	97626
answer	answer is ministerial correction date of answer 05/12/2022 answer text <p>The following table shows the number of patients on the transplant waiting list in the West Midlands as of 28 November 2022. Suspended patients refers to those who have been temporarily removed from the list.</p><table><tbody><tr><td><p>Active</p></td><td><p>Suspended</p></td><td><p>Total</p></td></tr><tr><td><p>Total</p></td><td><p>687</p></td><td><p>431</p></td><td><p>1,118</p></td></tr></tbody></table><p>Source: NHS Blood and Transplant</p><p>NHS Blood and Transplant does not hold the data on the average waiting time for organ donation in the West Midlands or the number of people removed from the waiting list in the West Midlands due to a clinical decision.</p><p>The following table shows the number of transplants which took place in the West Midlands in 2021/22 and 2022/23 as of 28 November.</p><table><tbody><tr><td><p>2021/22</p></td><td><p>2022/23 to date</p></td></tr><tr><td><p>Total</p></td><td><p>377</p></td><td><p>260</p></td></tr></tbody></table><p>Source: NHS Blood and Transplant</p><p> </p> answering member constituency Harborough answering member printed Neil O'Brien question first answered 05/12/2022 17:16:56 answering member 4679 label Biography information for Neil O'Brien previous answer version 39018 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4370 label Biography information for Jess Phillips

1525079

registered interest
date	21/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to improve the (a) identification and (b) referral process for dementia diagnosis.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	68546
answer	answer is ministerial correction date of answer 31/10/2022 answer text <p>NHS England is working with general practitioner IT system providers to reproduce the Dementia Quality Toolkit (DQT) using SNOMED coding. The DQT includes system searches which can be used by general practitioners to identify people whose records suggest that they might have dementia, but do not have a recorded diagnosis. Publication of the toolkit is anticipated by April 2023.</p><p>In 2021/22, the Government made £17 million available to clinical commissioning groups to address dementia waiting lists and increase the number of diagnoses. This included identifying areas of good practice in dementia diagnosis and provision of pre and post diagnostic support, which will be shared with dementia clinical networks and stakeholders. In 2022/23, NHS England has initiated a project to fund two trusts in each region to pilot the Diagnosing Advanced Dementia Mandate tool to improve diagnosis of dementia in care homes.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 31/10/2022 17:32:44 answering member 4527 label Biography information for Helen Whately previous answer version 27986 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4370 label Biography information for Jess Phillips

1525081

registered interest
date	21/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Dementia: Ethnic Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to ensure that people from ethnic minority communities are receiving timely dementia diagnoses.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	68547
answer	answer is ministerial correction date of answer 31/10/2022 answer text <p>NHS England has commissioned the Office for Health Improvement and Disparities’ Dementia Intelligence Network to investigate the underlying variation in dementia diagnosis rates in targeted areas in England. This investigation includes the assessment of population characteristics such as rurality, ethnicity and age to provide context for variation and enable targeted investigation and provision of support locally.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 31/10/2022 17:34:38 answering member 4527 label Biography information for Helen Whately previous answer version 27984 answering member constituency Harborough answering member printed Neil O'Brien answering member 4679 label Biography information for Neil O'Brien
tabling member	4370 label Biography information for Jess Phillips

1521449

registered interest
date	12/10/2022
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Birmingham Yardley
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve access to mental health services in Birmingham Yardley constituency.
tabling member constituency	Birmingham, Yardley
tabling member printed	Jess Phillips
uin	61943
answer	answer is ministerial correction date of answer 21/10/2022 answer text <p>In September we announced ‘Our Plan for Patients’, which outlines how we will increase access to National Health Service mental health and eating disorder services, including in Birmingham Yardley. Making it easier to access general practice through our ABCD priorities will expand this route as a gateway to mental health care.</p><p>Through the NHS Long Term Plan, we are investing an additional £2.3 billion a year by 2023/24 to expand these services for adults, children and young people in England, including in Walsall South.</p><p>We will invest approximately £1 billion in community mental health care for adults with severe mental illness, including eating disorders, by 2023/24 and an additional £53 million per year in children and young people's community eating disorder services to increase capacity in the 70 community eating disorder teams.</p> answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson question first answered 21/10/2022 13:21:03 answering member 4592 label Biography information for Dr Caroline Johnson previous answer version 23201 answering member constituency Sleaford and North Hykeham answering member printed Dr Caroline Johnson answering member 4592 label Biography information for Dr Caroline Johnson
tabling member	4370 label Biography information for Jess Phillips